Collagen

Collagen

Best for

Ease joint pain

Proven strong benefit for 8–26 weeks · 1 meta-analysis , n=3.5k

68 papers · 12 claims · 132 outcomes scored · 12 positive

Outcomes

What collagen actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Ease joint pain Proven strong benefit
large
10 meta-analyses n=3.5k Meta-analyzed 5–3000 mg 8–26 wk #2/18
Reduce pain and daily disability Large effect, needs confirmation
large
1 RCT n=60 40 mg 12 wk #2/5
Build firmer, denser skin Proven benefit
moderate
18 meta-analyses n=2.7k Meta-analyzed 2.5–12000 mL 4–26 wk #1/8
Reverse visible sun damage Promising early signal
moderate
2 RCTs n=152 1000 mg 12 wk #1/2
Boost skin hydration Proven modest benefit
small
15 meta-analyses n=5.7k Meta-analyzed 0.3–12000 mL 4–13 wk #1/13
Ease arthritis pain and joint inflammation Likely modest benefit
small
17 meta-analyses n=2.3k Meta-analyzed 2–10000 mg 8–26 wk #5/21
Smooth rough, uneven skin Faint early signal
small
6 RCTs n=282 2.5–1650 mg 8–26 wk #2/2
Reduce fine lines and wrinkles Faint early signal
small
5 RCTs n=76 10–1650 mg 8–13 wk #3/5
Reduce everyday pain intensity Proven but unnoticeable
trivial
6 meta-analyses n=3.4k Meta-analyzed 2.5–960 g 8–26 wk
Loosen stiff joints Likely real but unnoticeable
trivial
9 meta-analyses n=916 Meta-analyzed 2.5–10000 g 5–26 wk #6/9
Slow cartilage wear in knee arthritis Not enough research
trivial
4 RCTs n=166 10–3000 g 12–26 wk #9/9
Boost skin radiance Not enough research
trivial
2 RCTs n=44 50–1000 mL 8–12 wk #2/3

Risk profile

Adverse events and known drug interactions

Safety events

constipation moderate
diarrhea moderate
Nausea/vomiting mild
Abdominal pain/epigastric discomfort mild
Diarrhea mild
Liver dysfunction (transaminase increase) mild
Headache/dizziness mild
Itching/rash mild

Drug interactions

Cyclosporine major increases effect
Cucurbitacin B major increases concentration
Cisplatin major decreases effect
Clopidogrel moderate additive
Aspirin moderate additive
Cyclophosphamide minor decreases concentration

Co-studied with

Supplements that share evidence with collagen

Sources

  1. 1. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. (2013)
  2. 2. The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial. (2021)
  3. 3. Symptomatic and chondroprotective treatment with collagen derivatives in osteoarthritis: a systematic review. (2012)
  4. 4. A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy of a Hydrolyzed Chicken Collagen Type II Supplement in Alleviating Joint Discomfort. (2021)
  5. 5. Efficacy and safety of native type II collagen in modulating knee osteoarthritis symptoms: a randomised, double-blind, placebo-controlled trial. (2022)
  6. 6. Randomized, double-blind, four-arm pilot study on the effects of chicken essence and type II collagen hydrolysate on joint, bone, and muscle functions. (2023)
  7. 7. Collagen peptides supplementation improves function, pain, and physical and mental outcomes in active adults. (2023)
  8. 8. Analgesic efficacy of collagen peptide in knee osteoarthritis: a meta-analysis of randomized controlled trials. (2023)
  9. 9. Management and Amelioration of Knee Joint Osteoarthritis in Adults Using a Novel High-Functional Bovine Collagen Peptide as a Nutritional Therapy: A Double-Blind, Prospective, Multicentric, Randomized, Active and Placebo Controlled, Five-Arm, Clinical Study to Evaluate the Efficacy, Safety, and Tolerability. (2024)
  10. 10. Impact of Specific Bioactive Collagen Peptides on Joint Discomforts in the Lower Extremity during Daily Activities: A Randomized Controlled Trial. (2024)

Generated August 14, 2026

Want personalized recommendations?

Show me what works for me